COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,845 Articles (22,553 medRxiv, 8,292 bioRxiv)

Most recent first Previous |  Page 685: Articles 6841-6850  | Next

Antiviral T-cell Biofactory platform for SARS-CoV-2
Ssemadaali, M. A., Newmyer, S., Radhakrishnan, H., Arredondo, J., Javitz, H. S., Dandekar, S., Bhatnagar, P.
10.1101/2022.06.26.497669 — Posted: 2022-06-27
Vaccination saves lives: How do patients with chronic diseases and severe COVID-19 fare? Analysis from Indias National Clinical registry for COVID-19
Mukherjee, A., Kumar, G., Turuk, A., Bhalla, A., Bingi, T. C., Bhardwaj, P., Baruah, T. D., Mukherjee, S., Talukdar, A., Ray, Y., John, M., Khambholja, J. R., Patel, A. H., Bhuniya, S., Joshi, R., Menon, G. R., Sahu, D., Rao, V. V., Bhargava, B., Panda, S.
10.1101/2022.06.22.22276744 — Posted: 2022-06-27
Compliant citizens, defiant rebels or neither? Exploring changing COVID-19 vaccine attitudes and decisions in Bradford, UK: Findings from a follow-up qualitative study
Lockyer, B., Moss, R. H., Endacott, C., Islam, S., Sheard, L., Bradford Institute for Health Research Covid-19 Scientific Advisory Group
10.1101/2022.06.24.22276852 — Posted: 2022-06-27
IMMUNE PROFILES TO DISTINGUISH HOSPITALIZED VERSUS AMBULATORY COVID-19 CASES IN OLDER PATIENTS
Klingler, J., Lambert, G. S., Bandres, J. C., Emami-Gorizi, R., Nadas, A., Oguntuyo, K. Y., Amanat, F., PARIS Study Team, , Simon, V., Lee, B., Zolla-Pazner, S., Upadhyay, C., Hioe, C. E.
10.1101/2022.06.23.22276820 — Posted: 2022-06-27
The 2020 U.S. cancer screening deficit and the timing of adults' most recent screen: A population-based quasi-experiment
Semprini, J., Ranganathan, R.
10.1101/2022.06.24.22276836 — Posted: 2022-06-27
Factors Associated with Receipt and Parental Intent for COVID-19 Vaccination of Children Ages 5-11 years
Santibanez, T. A., Lendon, J. P., Singleton, J. A., Black, C. L., Zhou, T., Kriss, J. L., Jain, A., Elam-Evans, L. D., Masters, N. B., Peacock, G.
10.1101/2022.06.24.22276865 — Posted: 2022-06-27
Protection against Omicron BA.2 reinfection conferred by primary Omicron or pre-Omicron infection with and without mRNA vaccination
Carazo, S., Skowronski, D. M., Brisson, M., Barkati, S., Sauvageau, C., Brousseau, N., Gilca, R. M., Fafard, J., Talbot, D., Ouakki, M., Gilca, V., Carignan, A., Deceuninck, G., De wals, P., De Serres, G.
10.1101/2022.06.23.22276824 — Posted: 2022-06-27
Use of Chinese herbs to treat symptoms likely related to COVID-19: Survey analysis of licensed acupuncturists in the United States
Anderson, B. J., Zappa, M., Leininger, B., Taylor-Swanson, L. J.
10.1101/2022.06.23.22276829 — Posted: 2022-06-27
COVID-19 DISEASE IN PEDIATRIC EMERGENCY ROOM: THE DILEMMA OF CYCLE THRESHOLD VALUE
Timur, D., DEMIRPEK, U., DEMIRBAS, B. C., TURE, E., KORKMAZ, M. F., TIMUR, A.
10.1101/2022.06.23.22276825 — Posted: 2022-06-27
HIV and SARS-CoV-2 infection in postpartum Kenyan women and their infants
Begnel, E. R., Chohan, B. H., Ojee, E., Adhiambo, J., Owiti, P., Ogweno, V., Holland, L. A., Fish, C. S., Richardson, B. A., Khan, A. K., Maqsood, R., Lim, E., Lehman, D. A., Slyker, J., Kinuthia, J., Wamalwa, D., Gantt, S.
10.1101/2022.06.23.22276827 — Posted: 2022-06-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).